NovaBay Pharmaceuticals (NBY)
(Delayed Data from AMEX)
$0.14 USD
+0.01 (6.39%)
Updated May 22, 2024 04:00 PM ET
After-Market: $0.13 -0.01 (-7.01%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth A Momentum B VGM
Price, Consensus and EPS Surprise
NBY 0.14 +0.01(6.39%)
Will NBY be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for NBY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NBY
NovaBay Pharmaceuticals (NBY) Shows Fast-paced Momentum But Is Still a Bargain Stock
NBY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NBY
12 Health Care Stocks Moving In Wednesday's After-Market Session
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday